Bausch Health Companies (TSE:BHC) Stock Price Down 1.1% – Here’s What Happened

Shares of Bausch Health Companies Inc. (TSE:BHC) were down 1.1% during mid-day trading on Monday . The stock traded as low as C$6.97 and last traded at C$7.25. Approximately 421,881 shares traded hands during mid-day trading, a decline of 25% from the average daily volume of 559,367 shares. The stock had previously closed at C$7.33.

Wall Street Analysts Forecast Growth

A number of analysts have commented on BHC shares. Raymond James Financial raised Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Barclays raised Bausch Health Companies to a “hold” rating in a report on Monday, December 8th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Bausch Health Companies Price Performance

The firm has a 50 day moving average price of C$8.70 and a 200 day moving average price of C$9.12. The stock has a market capitalization of C$2.69 billion, a PE ratio of 17.26, a price-to-earnings-growth ratio of 0.21 and a beta of 0.60. The company has a current ratio of 1.47, a quick ratio of 0.58 and a debt-to-equity ratio of -3,835.02.

Bausch Health Companies (TSE:BHC) last released its earnings results on Wednesday, February 18th. The company reported C($0.41) earnings per share for the quarter. Bausch Health Companies had a net margin of 1.82% and a negative return on equity of 20.27%. The company had revenue of C$6.62 billion for the quarter. Research analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.